Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-18-036065
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-06 16:33:56
Reporting Period:
2018-01-30
Accepted Time:
2018-06-06 16:33:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1044378 Biocept Inc BIOC Services-Medical Laboratories (8071) 330757995
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1589616 Bruce Gerhardt C/o Biocept, Inc.
5810 Nancy Ridge Drive
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-30 25,000 $0.00 98,303 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2018-01-30 25,000 $0.00 25,000 $0.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 2018-01-30 2023-01-30 No 4 P Direct
Footnotes
  1. The Reporting Person purchased in a public offering 25,000 shares of common stock and warrants to purchase 25,000 shares of common stock at a combined purchase price of $0.45.
  2. Due to a rounding issue, the Reporting Person's prior holdings were overstated by one share.